GeneGo Licenses MetaCore Technology to Philips
News Aug 01, 2007
According to GeneGo, MetaCore is a flexible pathway analysis platform that can be utilized with or without experimental data. It contains a lot of domain and disease knowledge that is easily accessible to general users which answers day to day questions of what is upstream or downstream of this gene or how are these metabolites linked via pathways, relevant papers to specific diseases or all papers on a compound binding with a specific ligand.
"We are very pleased with Philips' decision to license MetaCore," said Julie Bryant, GeneGo's VP of Business Development. "We have seen a surge of diagnostic companies, such as Almac Diagnostics becoming GeneGo customers over the last couple of years, and Philips is the latest addition. We welcome the expansion of the scope of systems biology applications beyond drug discovery."
Genetic Variations in the Lungs Identify COPD RiskNews
Developmental genetic variations in the anatomy of the lung could indicate people at risk of COPD later in life, a study suggests.READ MORE
Proteasome Blocker Brings Glaucoma Gene Therapy CloserNews
An enhanced gene therapy technique that pairs a viral vector with a proteasome blockade has doubled the therapy's efficiency.READ MORE
New Class of Decoy Molecules that Prevent the Onset of PainNews
Researcher report a new method of reducing pain-associated behaviors with RNA-based medicine, creating a new class of decoy molecules that prevent the onset of pain.READ MORE